Equine Herpesvirus Respiratory Disease in Mules: What Owners Should Know

Equine herpesvirus respiratory disease is a contagious upper respiratory infection caused mainly by equine herpesvirus type 1 (EHV-1) and, in horses, EHV-4. Merck notes that EHV-1 causes disease in most equids, while EHV-4 is largely limited to horses. That matters for mules, because they can be exposed in mixed-equid settings such as barns, shows, sales, rescues, and transport.

In many mules, the respiratory form causes fever, lethargy, nasal discharge, and mild airway inflammation. Some animals have very subtle signs at first, especially if they have partial immunity from past exposure or vaccination history within the herd. Others may look more obviously sick, with poor appetite and enlarged lymph nodes under the jaw.

A key challenge is that herpesviruses can become latent, meaning the virus may stay in the body after infection and reactivate later during stress, transport, crowding, illness, or immune suppression. That is one reason outbreaks can seem to appear suddenly in groups of equids.

Most respiratory cases improve with supportive care, but EHV-1 deserves extra caution because it can also be linked to neurologic disease and, in breeding animals, abortion. If your mule has fever plus weakness, stumbling, trouble urinating, or rapid decline, contact your vet right away.

This disease is caused by infection with equine herpesvirus, most importantly EHV-1 in mules and other non-horse equids. The virus spreads mainly through respiratory secretions, including nose-to-nose contact, coughing, snorting, and contaminated hands, tack, buckets, lead ropes, trailers, and shared equipment.

Exposure risk rises when equids are housed closely together or moved frequently. Travel, shows, auctions, new arrivals, hospital visits, and crowded boarding situations all increase the chance of contact with a shedding animal. A mule does not have to look very sick to spread virus. Some infected equids shed before signs are obvious, and some have only mild illness.

Another important cause of new cases is reactivation of latent infection. After an earlier infection, herpesvirus can remain dormant in the body. Stress, transport, illness, or corticosteroid exposure may allow the virus to reactivate and shed again.

Because fever and nasal discharge can also be caused by influenza, strangles, equine viral arteritis, and other respiratory infections, your vet will usually consider EHV as part of a broader infectious respiratory disease workup rather than assuming one cause from signs alone.

Diagnosis starts with history and exam findings. Your vet will ask about recent travel, new herd additions, exposure to horses with fever or neurologic signs, vaccination history in the group, and whether other equids on the property are affected. Temperature trends are especially helpful because fever can be the first clue.

The most common tests are PCR on a nasal swab and PCR on whole blood. Merck and AAEP guidance both support PCR as the main practical test for active EHV-1 or EHV-4 infection, with nasal swabs helping detect shedding and blood testing helping identify viremia. In some cases, repeat testing 24 to 72 hours later is recommended if suspicion remains high.

Your vet may also run a CBC, fibrinogen, or serum chemistry panel to look for inflammation, dehydration, or other illness. If there is concern for pneumonia or a secondary bacterial infection, additional testing may include thoracic imaging or airway sampling. If neurologic signs are present, the workup becomes more urgent and more extensive.

Because no single test answers every question, results are interpreted alongside the mule's signs, timing of illness, and herd situation. A negative test does not always fully rule out infection, especially if the sample was taken early, late, or during intermittent shedding.

Prevention depends on biosecurity plus vaccination strategy for the herd, not vaccination alone. AAEP and Merck both emphasize that EHV control works best when equids with fever or respiratory signs are isolated quickly, temperatures are monitored during risk periods, and shared equipment is minimized. New arrivals should be separated from the resident group for a quarantine period directed by your vet, especially after travel, sale barns, or events.

Good daily habits matter. Avoid nose-to-nose contact with unfamiliar equids. Do not share buckets, bits, towels, or grooming tools between groups. Handle isolated animals last, and wash hands or change gloves between animals when disease is suspected. Clean trailers and stalls between uses.

Vaccines for EHV-1 and EHV-4 are available and are used to help reduce respiratory disease risk and shedding, but they do not provide complete protection and are not labeled to prevent the neurologic form. Your vet can help decide whether your mule should be included in a herd vaccination program based on exposure risk, travel, housing, and contact with horses.

If one equid on the property develops fever, act early. Separate that animal, start temperature checks on exposed animals, pause movement on and off the property until your vet advises otherwise, and build a testing plan that matches the situation. Early containment is often the most practical way to protect the rest of the herd.